Nuvaira Inc.
3750 Annapolis Lane North
Suite 105
Minneapolis, MN 55447
Main 763.450.2800
info@nuvaira.com
© 2019 Nuvaira Inc. All rights reserved.
Nuvaira Inc.
3750 Annapolis Lane North
Suite 105
Minneapolis, MN 55447
Main 763.450.2800
info@nuvaira.com
© 2019 Nuvaira Inc. All rights reserved.
Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial
/in Uncategorized /by Amy WolterNovel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2019 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology assessment agency) into its Forfait Innovation program. The program is designed to fast-track novel medical devices […]
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
/in Uncategorized /by Amy WolterMarket Development Veteran Lisa Rogan Joins Nuvaira’s Executive Team MINNEAPOLIS, Feb 11, 2019 – Nuvaira, a developer of novel therapeutic medical devices to treat obstructive lung diseases, announced today it has closed a $79 million equity financing led by U.S. Venture Partners, with Endeavour Vision, Qiming Venture Partners, Lightstone Ventures and Richard King Mellon Foundation […]